Both Serotonin and Dopamine need to be pushed toward the therapeutic range AND in The Phase 3 Respon...
Download
1 / 12

Part 2 - PowerPoint PPT Presentation


  • 435 Views
  • Updated On :

Both Serotonin and Dopamine need to be pushed toward the therapeutic range AND in The Phase 3 Response™. The 3 phase response of Urinary Serotonin and Dopamine. Urinary Neurotransmitters. Are Not Systemic Neurotransmitter Excreted into the Urine.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Part 2' - albert


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript


The 3 phase response of Urinary Serotonin and Dopamine therapeutic range AND in The Phase 3 Response™


Urinary neurotransmitters
Urinary Neurotransmitters therapeutic range AND in The Phase 3 Response™

  • Are Not Systemic Neurotransmitter Excreted into the Urine

Urinary Neurotransmitters are Synthesized by the Kidneys


URINARY MASTER NEUROTRANSMITTERS AND DISEASES therapeutic range AND in The Phase 3 Response™

URINARY SEROTONIN: In random testing, 7% of people have urinary Serotonin levels above the reference range reported by the lab.


URINARY MASTER NEUROTRANSMITTERS AND DISEASES therapeutic range AND in The Phase 3 Response™

URINARY SEROTONIN:86.6% of patients not being actively treated with amino acids, but who have been diagnosed with a neurotransmitter disease, have urinary Serotonin levels above the reference range reported by the lab.


URINARY MASTER NEUROTRANSMITTERS AND DISEASES therapeutic range AND in The Phase 3 Response™

URINARY SEROTONIN: Labs with flawed assay techniques may report that none of the patients have elevated urinary neurotransmitter levels


URINARY MASTER NEUROTRANSMITTERS AND DISEASES therapeutic range AND in The Phase 3 Response™

Successful treatment depends upon being able to properly identify elevated urinary neurotransmitter levels.


URINARY MASTER NEUROTRANSMITTERS AND DISEASES therapeutic range AND in The Phase 3 Response™

Urine samples must be collected 5 to 6 hours before bedtime, NOT in the AM.


URINARY MASTER NEUROTRANSMITTERS AND DISEASES therapeutic range AND in The Phase 3 Response™

Urine samples must be assayed in a lab with the experience and the ability to interpret the assay.


INAPPROPRIATE EXCRETION OF NEUROTRANSMITTERS therapeutic range AND in The Phase 3 Response™

94.6% of patients diagnosed with a neurotransmitter disease, not under treatment with amino acids, have inappropriate excretion of one or more neurotransmitters in the lab assays performed prior to treatment.


INAPPROPRIATE EXCRETION OF NEUROTRANSMITTERS therapeutic range AND in The Phase 3 Response™

Proper use of amino acids corrects the inappropriate excretion of neurotransmitters, as well as provides a relief of disease symptoms.


ad